CRC Oncology

CRC Oncology is a contract research organization dedicated to promoting innovative oncology drugs and advanced cell therapies globally.

[CRC Oncology @crconcology]

U.S. FDA Grants Cellular Biomedicine Group Clearance of the IND Application for C-CAR039, a Bi-Specific CAR-T Cell Therapy for Relapsed/Refractory B-cell Non-Hodgkin Lymphomas

Press: https://t.co/XKzGJIp2pw

[CRC Oncology @crconcology]

Happy holidays from CRC Oncology!

[CRC Oncology @crconcology]

FDA grants clearance to proceed with clinical development of TransThera Biosciences' drug candidate, TT-00920.

Press: https://t.co/DiBfGQQWSG

#IND #clinicaldevelopment #transtherabio

[CRC Oncology @crconcology]

FDA grants Orphan Drug Designation to TransThera's lead candidate, TT-00420, for the treatment of cholangiocarcinoma.

Press: https://t.co/qiTs8unOgi

[CRC Oncology @crconcology]

CRC Oncology was honored to participate in last week's Fourth National Postdoctoral Forum on Drug Safety and Regulation.

Press: https://t.co/l79OPPYWf1

[Alliance for Regenerative Medicine (ARM) @alliancerm]

ARM's newly released Rare Disease Report features a breakdown of 587 regenerative medicine clinical trials in rare disease from 323 cell & gene therapy developers active in this space - https://t.co/rKiIQbajqD #RareDiseaseDay #RareDiseaseWeek

[FDA Oncology @FDAOncology]

Need #oncology #hematology #drugdevelopment guidance? Check out our new web page listing of recent #FDAOncology guidances: https://t.co/dAyGIIbBaW

[ASCO @ASCO]

Increasing access to clinical trials for patients of every background helps to ensure every person who is eligible and wants to enroll can, and makes the results of the trial more relevant to a larger population https://t.co/dqVNZDbWvl #ASCOconnection

[CRC Oncology @crconcology]

CRC is kicking off the new year by announcing the initiation of the Phase I clinical trial of TT-00420.
Press Release: https://t.co/aCx5ByanZS

[CRC Oncology @crconcology]

CRC has arrived at #ASH18 ! Come say hi to us at Booth 14 this weekend!

[CRC Oncology @crconcology]

"It is our mission and commitment to connect western and eastern worlds and bring global experts together."

Today, the Cellular Biomedicine Group opened their doors to international attendees of this year's Advanced Cell Therapy Shanghai Summit (ACTSS).

[Phacilitate @Phacilitate]

Cellular Biomedicine Group (CBMG) open GMP doors to international attendees: https://t.co/G7rNZA7WC3

They shared their progress plan for the next 12-18 months with #ACTSS2018 attendees.

Don't miss out & be part of the event: https://t.co/dEbDM4BHZG

#phacilitate @crconcology

[CRC Oncology @crconcology]

CRC Oncology's Beijing Office is now open!

PRESS RELEASE: https://t.co/vsfdVvVj77

[UT MD Anderson @UTMDAnderson]

What is #immunotherapy? Learn how #NobelPrize winner Dr. Jim Allison's work has transformed the way we treat cancer. #endcancer

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

Congrats Dr. Jim Allison, co-winner of the #NobelPrize in Medicine for his discovery of cancer therapy by inhibition of negative immune regulation, who conducted some of his award-winning research right here at MSK. Learn how this type of #immunotherapy works in 60-seconds.

[CRC Oncology @crconcology]

CRC Oncology is excited to announce the success of our first IND submission with TransThera Biosciences!

#cancer #FDA #oncology #ind #drugdevelopment
https://t.co/V7MPkeDOsB

[CRC Oncology @crconcology]

Thank you @Phacilitate for the opportunity to speak at #PLE2018 !

[Phacilitate @Phacilitate]

Is there a real opportunity in China? @crconcology begins the workshop on day two by explaining the GMP facility opportunities
#PLE2018 #advancedtherapies #China

[Phacilitate @Phacilitate]

Did you know that there are more CAR-T trials being registered and carried out in China than in Europe and America? Find out more about this market and download the brochure today: https://t.co/9BmcNuB6Rr

#actss2018 #phacilitate #celltherapy #shanghai

[Phacilitate @Phacilitate]

ACTSS 2018 will explore developments in global regulations in #cellgenetherapy, discuss critical insights into cGMP #manufacturing best practices & explore next gen. technologies & their potential to shape the autologous #CART landscape in the next 3-5 yrs https://t.co/uNFPZLKQTX

[AP Health & Science @APHealthScience]

Gene therapy has advanced far enough that special oversight of experiments is no longer needed, heads of @NIH and @US_FDA say. Story by @MMarchioneAP https://t.co/J4hWm3Dhi8

[NPR @NPR]

CAR-T therapies are among the most exciting developments in cancer research in years — one of several approaches that harness the immune system to fight cancer. https://t.co/G8ATOJOFWB